Eucure (beijing) Biopharma Co., Ltd.

Biocytogen Pharmaceuticals (beijing) Co., Ltd.

Jingshu Xie

Chen Wang

Yuelei Shen

Yanan Guo

Fang Yang

Jian Ni

Chengyuan Lu

Chunyan Dong

Yunyun Chen

Xiaodong Cheng

This disclosure relates to anti-PD-1 (Programmed Cell Death Protein 1) antibodies, antigen-binding fragments, and the uses thereof.

Anti-PD-1 antibodies and methods of treating cancer

This disclosure relates to anti-CD40 (TNF Receptor Superfamily Member 5) antibodies, antigen-binding fragments, and the uses thereof.

Anti-CD40 antibodies and uses thereof

This disclosure relates to anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4 or CTLA-4) antibodies, antigen-binding fragments, and the uses thereof.

Anti-CTLA4 antibodies and uses thereof

This disclosure relates to anti-human OX40 (TNF Receptor Superfamily Member 4, or TNFRSF4) antibodies, antigen-binding fragments, and the uses thereof.

Anti-OX40 antibodies and uses thereof

Anti-PD-1 antibodies and uses thereof

This disclosure relates to anti-TNFRSF9 (tumor necrosis factor receptor superfamily member 9) antibodies, antigen-binding fragments, and the uses thereof.

Anti-TNFRSF9 antibodies and uses thereof

This disclosure relates to anti-OX40 (TNF Receptor Superfamily Member 4, or TNFRSF4) antibodies, antigen-binding fragments, and the uses thereof.

Growing community of inventors

Beijing, China

Jingshu Xie